Here are the four additions:
1. Laurie Huard, now the company’s COO, previously served as the vice president of operations at Helomics, a molecular diagnostics company focused on personalized healthcare.
2. Karol Ford, now the company’s vice president of sales and marketing, previously worked with Progenity, a genetics reference laboratory.
3. Tania Obranovich, PhD, now the company’s vice president of intellectual property, legal affairs and compliance, previously practiced as a partner at an intellectual property firm in Australia.
4. John Alsobrook II, PhD, now the company’s clinical laboratory director, previously served as the chief science officer at DermTech, a molecular diagnostic dermatology company.
Clinical Genomics is gearing up to launch a two-gene circulating tumor DNA blood test for postoperative monitoring of colorectal cancer.
More articles on gastroenterology and endoscopy:
FMT proves long-term treatment for colonic bacterial infection: 3 study insights
Are patients with elderly onset IBD at increased risk for cancer? 3 study insights
AGA encourages gastroenterologists to watch 3 key policy areas
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.